GlassScriptPhysician profile
Timothy R Holmes
NPI 1356546790
$36,566.43
in general payments reported to CMS, 2019-2025
22 companies · $1,039 in 2025
The $1,039 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $12K · 2021: $6,474 · 2022: $1,735 · 2023: $1,294 · 2024: $1,391 · 2025: $1,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,724.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $34,540.39 | 2019-2025 | Prophecy, Hoffmann, Citrefix |
| Organogenesis INC. | $290.77 | 2022-2025 | Ocmp, Simplimax, Puraply Am |
| Treace Medical Concepts, INC. | $225.23 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $206.97 | 2019-2023 | Jublia |
| Sanara Medtech INC. | $166.94 | 2024 | Celleraterx |
| Horizon Therapeutics Plc | $160.65 | 2020 | |
| Bone Support INC. | $141.77 | 2025 | Cerament G, Ceramentbone Void Filler |
| Access Pro Medical, LLC | $140.75 | 2025 | Matriderm |
| Kerecis Limited | $116.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $114.90 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $95.08 | 2019-2025 | Grafix Pl, Stravix Pl |
| Gramercy Extremity Orthopedics LLC | $78.32 | 2025 | |
| In2bones USA, LLC | $53.11 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $46.83 | 2023 | Seglentis |
| Arteriocyte Medical Systems, INC. | $36.66 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $32.86 | 2023 | |
| Medshape, INC. | $30.58 | 2022 | |
| Cdc Medical LLC | $28.47 | 2022 | |
| Cosa Medical, LLC | $22.86 | 2024 | |
| 4web, INC. | $22.30 | 2019 | |
| Sandoz INC. | $14.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,130.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.